Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genotropin for GHD after TBI
NCT00555009Phase 4Terminated
- Sponsor
- Pfizer
- Start
- Mar 2008
- Primary completion
- Jan 2009
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 6
01
Overview
Phase 4, randomised, double-blind trial in growth hormone deficiency (GHD) comparing Genotropin with Placebo (2 arms). Primary endpoint: Change From Baseline in the Cognitive Function (CogState™) Composite Score at 36 weeks. Started Mar 2008; status: terminated.
02
Drugs
genotropin miniquick
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT00555009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00555009.